Helicobacter Pylori Non-Invasive Testing Market by Type and Application- Global Industry Analysis & Forecast to 2027

Published On : March 2021 Pages : 157 Category: Pharma & Healthcare Report Code : HC0316265

Helicobacter Pylori Non-Invasive Testing Market By Type (Serology Test, Stool Antigen Test, Urea Breath Test) and Application (Hospitals, Clinics, Diagnostic Laboratories)- Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Helicobacter Pylori Non-Invasive Testing Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Helicobacter pylori (H. pylori) is a gram negative spiral bacteriumHelicobacter Pylori Non-Invasive Testing tests are based on circulating antibodies to H. pylori. There are three main methods for these tests: the enzyme‐linked immunosorbent assay (ELISA) test, latex agglutination tests, and Western blotting.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global Helicobacter Pylori Non-Invasive Testing Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • SouthAmerica
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Turkey
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • DiaSorin S.p.A.
  • Meridian Bioscience
  • Exalenz Bioscience Ltd.
  • Abbott
  • Thermo Fisher Scientific, Inc
  • CertestBiotec S.L.
  • Sekisui Diagnostics (Sekisui Chemical Co. Ltd.)
  • CorisBioconcept SPRL
  • Shenzhen Zhonghe Headway Bio-Sci& Tech Co., Ltd.
  • Bio-Rad Laboratories, Inc.

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2021 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Helicobacter Pylori Non-Invasive Testing Market, ByType, Estimates and Forecast, 2017-2027 ($Million)

o    Serology Test

o    Stool Antigen Test

o    Urea Breath Test

·         Helicobacter Pylori Non-Invasive Testing Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)

o    Hospitals

o    Clinics

o    Diagnostic Laboratories

·         Helicobacter Pylori Non-Invasive Testing Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o    DiaSorin S.p.A.

o    Meridian Bioscience

o    Exalenz Bioscience Ltd.

o    Abbott

o    Thermo Fisher Scientific, Inc

o    CertestBiotec S.L.

o    Sekisui Diagnostics (Sekisui Chemical Co. Ltd.)

o    CorisBioconcept SPRL

o    Shenzhen Zhonghe Headway Bio-Sci& Tech Co., Ltd.

o    Bio-Rad Laboratories, Inc.

·         Helicobacter Pylori Non-Invasive Testing Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Helicobacter Pylori Non-Invasive Testing Market, By Country

o    U.S. Helicobacter Pylori Non-Invasive Testing Market

o    Canada Helicobacter Pylori Non-Invasive Testing Market

o    Mexico Helicobacter Pylori Non-Invasive Testing Market

o    Europe

§  Europe Helicobacter Pylori Non-Invasive Testing Market, By Country

o    UK Helicobacter Pylori Non-Invasive Testing Market

o    Germany Helicobacter Pylori Non-Invasive Testing Market

o    France Helicobacter Pylori Non-Invasive Testing Market

o    Russia Helicobacter Pylori Non-Invasive Testing Market

o    Italy Helicobacter Pylori Non-Invasive Testing Market

o    Rest of Europe Helicobacter Pylori Non-Invasive Testing Market

o    Asia-Pacific

§  Asia-Pacific Helicobacter Pylori Non-Invasive Testing Market, By Country

o    China Helicobacter Pylori Non-Invasive Testing Market

o    Japan Helicobacter Pylori Non-Invasive Testing Market

o    South Korea Helicobacter Pylori Non-Invasive Testing Market

o    India Helicobacter Pylori Non-Invasive Testing Market

o    Southeast Asia Helicobacter Pylori Non-Invasive Testing Market

o    Rest of Asia-Pacific Helicobacter Pylori Non-Invasive Testing Market

o    South America

§  South America Helicobacter Pylori Non-Invasive Testing Market

o    Brazil Helicobacter Pylori Non-Invasive Testing Market

o    Argentina Helicobacter Pylori Non-Invasive Testing Market

o    Columbia Helicobacter Pylori Non-Invasive Testing Market

o    Rest of South America Helicobacter Pylori Non-Invasive Testing Market

o    Middle East and Africa

§  Middle East and Africa Helicobacter Pylori Non-Invasive Testing Market

o    Saudi Arabia Helicobacter Pylori Non-Invasive Testing Market

o    UAE Helicobacter Pylori Non-Invasive Testing Market

o    Egypt Helicobacter Pylori Non-Invasive Testing Market

o    Nigeria Helicobacter Pylori Non-Invasive Testing Market

o    South Africa Helicobacter Pylori Non-Invasive Testing Market

o    TurkeyHelicobacter Pylori Non-Invasive Testing Market

o    Rest of MEA Helicobacter Pylori Non-Invasive Testing Market 

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Helicobacter Pylori Non-Invasive Testing  Market, By Type

5.1.     Introduction

5.2.     Global Helicobacter Pylori Non-Invasive Testing  Revenue and Market Share by Type (2017-2021)

5.2.1.  Global Helicobacter Pylori Non-Invasive Testing  Revenue and Revenue Share by Type (2017-2021)

5.3.     Serology Test

5.3.1.  Global Serology Test Revenue and Growth Rate (2017-2021)

5.4.     Stool Antigen Test

5.4.1.  Global Stool Antigen Test Revenue and Growth Rate (2017-2021)

5.5.     Urea Breath Test

5.5.1.  Global Urea Breath Test Revenue and Growth Rate (2017-2021)

6.       Helicobacter Pylori Non-Invasive Testing  Market, By Applications

6.1.     Introduction

6.2.     Global Helicobacter Pylori Non-Invasive Testing  Revenue and Market Share by Applications (2017-2021)

6.2.1.  Global Helicobacter Pylori Non-Invasive Testing  Revenue and Revenue Share by Applications (2017-2021)

6.3.     Hospitals

6.3.1.  Global Hospitals Revenue and Growth Rate (2017-2021)

6.4.     Clinics

6.4.1.  Global Clinics Revenue and Growth Rate (2017-2021)

6.5.     Diagnostic Laboratories

6.5.1.  Global Diagnostic Laboratories Revenue and Growth Rate (2017-2021)

7.       Helicobacter Pylori Non-Invasive Testing  Market, By Region

7.1.     Introduction

7.2.     Global Helicobacter Pylori Non-Invasive Testing  Revenue and Market Share by Regions

7.2.1.  Global Helicobacter Pylori Non-Invasive Testing  Revenue by Regions (2017-2021)

7.3.     North America Helicobacter Pylori Non-Invasive Testing  by Countries

7.3.1.  North America Helicobacter Pylori Non-Invasive Testing  Revenue and Growth Rate (2017-2021)

7.3.2.  North America Helicobacter Pylori Non-Invasive Testing  Revenue (Million USD) by Countries (2017-2021)

7.3.3.  United States

7.3.3.1.  United States Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.4.  Canada

7.3.4.1.  Canada Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.5.  Mexico

7.3.5.1.  Mexico Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.     Europe Helicobacter Pylori Non-Invasive Testing  by Countries

7.4.1.  Europe Helicobacter Pylori Non-Invasive Testing  Revenue and Growth Rate (2017-2021)

7.4.2.  Europe Helicobacter Pylori Non-Invasive Testing  Revenue (Million USD) by Countries (2017-2021)

7.4.3.  Germany

7.4.3.1.  Germany Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.4.  France

7.4.4.1.  France Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.5.  UK

7.4.5.1.  UK Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.6.  Russia

7.4.6.1.  Russia Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.7.  Italy

7.4.7.1.  Italy Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.     Asia-Pacific Helicobacter Pylori Non-Invasive Testing  by Countries

7.5.1.  Asia-Pacific Helicobacter Pylori Non-Invasive Testing  Revenue and Growth Rate (2017-2021)

7.5.2.  Asia-Pacific Helicobacter Pylori Non-Invasive Testing  Revenue (Million USD) by Countries (2017-2021)

7.5.3.  China

7.5.3.1.  China Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.4.  Japan

7.5.4.1.  Japan Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.5.  Korea

7.5.5.1.  Korea Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.6.  India

7.5.6.1.  India Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.     South America Helicobacter Pylori Non-Invasive Testing  by Countries

7.6.1.  South America Helicobacter Pylori Non-Invasive Testing  Revenue and Growth Rate (2017-2021)

7.6.2.  South America Helicobacter Pylori Non-Invasive Testing  Revenue (Million USD) by Countries (2017-2021)

7.6.3.  Brazil

7.6.3.1.  Brazil Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.4.  Argentina

7.6.4.1.  Argentina Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.5.  Columbia

7.6.5.1.  Columbia Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.     Middle East and Africa Helicobacter Pylori Non-Invasive Testing  by Countries

7.7.1.  Middle East and Africa Helicobacter Pylori Non-Invasive Testing  Revenue and Growth Rate (2017-2021)

7.7.2.  Middle East and Africa Helicobacter Pylori Non-Invasive Testing  Revenue (Million USD) by Countries (2017-2021)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.5.  Egypt

7.7.5.1.  Egypt Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.7.  South Africa

7.7.7.1.  South Africa Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.8.  Turkey

7.7.8.1.  Turkey Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2017-2021)

8.       Company Profiles

8.1.     DiaSorin S.p.A.

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Meridian Bioscience

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Exalenz Bioscience Ltd.

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Abbott

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Thermo Fisher Scientific, Inc

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Certest Biotec S.L.

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Sekisui Diagnostics (Sekisui Chemical Co. Ltd.)

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     CorisBioconcept SPRL

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

8.10. Bio-Rad Laboratories, Inc.

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.      Financial Overview

9.       Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.1.     Global Helicobacter Pylori Non-Invasive Testing  Revenue (Millions USD) and Growth Rate (2022-2027)

9.2.     Helicobacter Pylori Non-Invasive Testing  Market Forecast by Regions (2022-2027)

9.2.1.  North America Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.1.1.  United States Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.1.2.  Canada Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.1.3.  Mexico Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.2.  Europe Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.2.1.  Germany Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.2.2.  France Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.2.3.  UK Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.2.4.  Russia Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.2.5.  Italy Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.2.6.  Rest of Europe Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.3.  Asia-Pacific Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.3.1.  China Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.3.2.  Japan Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.3.3.  Korea Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.3.4.  India Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.3.5.  Southeast Asia Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.3.6.  Rest of Asia-Pacific Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.4.  South America Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.4.1.  Brazil Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.4.2.  Argentina Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.4.3.  Columbia Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.4.4.  Rest of South America Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.5.  Middle East and Africa Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.5.1.  Saudi Arabia Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.5.2.  United Arab Emirates Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.5.3.  Egypt Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.5.4.  Nigeria Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.5.5.  South Africa Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.5.6.  Turkey Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.2.5.7.  Rest of Middle East and Africa Helicobacter Pylori Non-Invasive Testing  Market Forecast (2022-2027)

9.3.     Helicobacter Pylori Non-Invasive Testing  Market Forecast by Type (2022-2027)

9.3.1.  Helicobacter Pylori Non-Invasive Testing  Forecast by Type (2022-2027)

9.3.2.  Helicobacter Pylori Non-Invasive Testing  Market Share Forecast by Type (2022-2027)

9.4.     Helicobacter Pylori Non-Invasive Testing  Market Forecast by Applications (2022-2027)

9.4.1.  Helicobacter Pylori Non-Invasive Testing  Forecast by Applications (2022-2027)

9.4.2.  Helicobacter Pylori Non-Invasive Testing  Market Share Forecast by Applications (2022-2027)


List of Tables

List of Tables and Figures:

Figure United States Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Helicobacter Pylori Non-Invasive Testing Revenue and Revenue Share by Type (2017-2019)
Figure Global Serology Test Revenue and Growth Rate (2017-2019)
Figure Global Stool Antigen Test Revenue and Growth Rate (2017-2019)
Figure Global Urea Breath Test Revenue and Growth Rate (2017-2019)
Table Global Helicobacter Pylori Non-Invasive Testing Revenue and Revenue Share by Applications (2017-2019)
Figure Global Hospitals Revenue and Growth Rate (2017-2019)
Figure Global Clinics Revenue and Growth Rate (2017-2019)
Figure Global Diagnostic Laboratories Revenue and Growth Rate (2017-2019)
Table Global Helicobacter Pylori Non-Invasive Testing Revenue by Regions (2017-2019)
Figure North America Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure North America Helicobacter Pylori Non-Invasive Testing Revenue and Growth Rate (2017-2019)
Figure North America Helicobacter Pylori Non-Invasive Testing by Countries (2017-2019)
Figure North America Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) by Countries (2017-2019)
Figure United States Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure United States Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Canada Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Mexico Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Europe Helicobacter Pylori Non-Invasive Testing Revenue and Growth Rate (2017-2019)
Figure Europe Helicobacter Pylori Non-Invasive Testing by Countries (2017-2019)
Figure Europe Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) by Countries (2017-2019)
Figure Germany Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Germany Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure France Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure UK Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Russia Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Italy Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Rest of Europe Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Asia-Pacific Helicobacter Pylori Non-Invasive Testing Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Helicobacter Pylori Non-Invasive Testing by Countries (2017-2019)
Figure Asia-Pacific Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) by Countries (2017-2019)
Figure China Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure China Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Japan Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Korea Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure India Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Southeast Asia Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure South America Helicobacter Pylori Non-Invasive Testing Revenue and Growth Rate (2017-2019)
Figure South America Helicobacter Pylori Non-Invasive Testing by Countries (2017-2019)
Figure South America Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Brazil Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Argentina Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Columbia Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Rest of South America Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Middle East and Africa Helicobacter Pylori Non-Invasive Testing Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Helicobacter Pylori Non-Invasive Testing by Countries (2017-2019)
Figure Middle East and Africa Helicobacter Pylori Non-Invasive Testing Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Saudi Arabia Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure United Arab Emirates Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Egypt Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Nigeria Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure South Africa Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Turkey Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Helicobacter Pylori Non-Invasive Testing Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Table DiaSorin S.p.A. Helicobacter Pylori Non-Invasive Testing Financial Overview
Table Meridian Bioscience Helicobacter Pylori Non-Invasive Testing Financial Overview
Table Exalenz Bioscience Ltd. Helicobacter Pylori Non-Invasive Testing Financial Overview
Table Abbott Helicobacter Pylori Non-Invasive Testing Financial Overview
Table Thermo Fisher Scientific, Inc Helicobacter Pylori Non-Invasive Testing Financial Overview
Table Certest Biotec S.L. Helicobacter Pylori Non-Invasive Testing Financial Overview
Table Sekisui Diagnostics (Sekisui Chemical Co. Ltd.) Helicobacter Pylori Non-Invasive Testing Financial Overview
Table CorisBioconcept SPRL Helicobacter Pylori Non-Invasive Testing Financial Overview
Table Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd. Helicobacter Pylori Non-Invasive Testing Financial Overview
Table Bio-Rad Laboratories, Inc. Helicobacter Pylori Non-Invasive Testing Financial Overview
Figure Global Helicobacter Pylori Non-Invasive Testing Revenue (Millions USD) and Growth Rate (2019-2027)
Table Helicobacter Pylori Non-Invasive Testing Market Forecast by Regions (2019-2027)
Figure North America Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure United States Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Canada Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Mexico Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Europe Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Germany Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure France Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure UK Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Russia Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Italy Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Rest of Europe Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Asia-Pacific Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure China Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Japan Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Korea Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure India Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Southeast Asia Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure South America Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Brazil Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Argentina Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Columbia Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Rest of South America Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Middle East and Africa Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Saudi Arabia Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure United Arab Emirates Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Egypt Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Nigeria Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure South Africa Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Turkey Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Helicobacter Pylori Non-Invasive Testing Market Forecast (2019-2027)
Figure Global Helicobacter Pylori Non-Invasive Testing Forecast by Type (2019-2027)
Figure Global Helicobacter Pylori Non-Invasive Testing Market Share Forecast by Type (2019-2027)
Figure Global Helicobacter Pylori Non-Invasive Testing Forecast by Type (2019-2027)
Figure Global Helicobacter Pylori Non-Invasive Testing Forecast by Applications (2019-2027)
Figure Global Helicobacter Pylori Non-Invasive Testing Market Share Forecast by Applications (2019-2027)
Figure Global Helicobacter Pylori Non-Invasive Testing Forecast by Applications (2019-2027)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*